News

Psilocybin, the main psychoactive ingredient in magic mushrooms, can alleviate depression for at least five years after a ...
A new study from the American Cancer Society’s medical journal found that psilocybin — the active ingredient in “magic ...
A small pilot study published in the journal Psychedelic Medicine suggests that psilocybin-assisted psychotherapy might help ...
New research shows a single dose leads to 'robust' reductions in depression and anxiety up to 2 years afterward.
The psilocybin found in "magic mushrooms" might be key to quelling depression among people battling cancer, a new study found ...
Psilocybin, the active ingredient in magic mushrooms, might just revolutionize how depression and anxiety are treated in ...
A single dose of psilocybin provided sustained reductions in depression and anxiety among cancer patients diagnosed with ...
New results from a clinical trial reveal that a single dose of psilocybin—a naturally occurring psychedelic compound found in ...
For cancer patients with a major depressive disorder, a single dose of psilocybin combined with psychological support can ...
New research shows psilocybin can produce lasting reductions in depression and anxiety in cancer patients with major ...
New results from a clinical trial reveal that a single dose of psilocybin-a naturally occurring psychedelic compound found in ...
Psilocybin therapy improved cognitive performance, reduced mood dysfunction, motor, and nonmotor symptoms in patients with Parkinson disease.